Search Results 251-260 of 16217 for anti-TNF drugs

1. Tocilizumab-anoh (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Tocilizumab-anoh injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

2. Oxtriphylline and guaifenesin (oral route) - Side effects & dosage - Mayo Clinic

   Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... medicines. Adinazolam; Alprazolam ...

3. Diphenhydramine and naproxen (oral route) - Side effects & dosage - Mayo Clinic

   Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that is used in this combination to relieve inflammation, swelling, and pain. This medicine is ...

4. Drug allergy - Diagnosis and treatment - Mayo Clinic

   Learn which medicines are more likely to cause an allergic reaction, what symptoms look like and what treatments can calm such a reaction.

5. Alzheimer's treatments: What's on the horizon? - Mayo Clinic

   The medicines prevent amyloid plaques in the brain from clumping. Lecanemab is given as an IV infusion every two weeks. Your care team likely will watch for ...

6. Drugs and Supplements that Start with F - Mayo Clinic

   Drugs and Supplements. Search prescription and over-the-counter drugs . ... Anti-inhibitor coagulant complex (intravenous route). Feiba-VH. Also known as.

7. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

   This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.

8. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma - Mayo Clinic

   About this study. This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called ...

9. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

   Any biologic targeting immune response other than an anti-TNF within 12 weeks prior to screening endoscopy visit; Other advanced small molecule treatments ...

10. Focus Areas - Rheumatology - Mayo Clinic Research

    ... anti-rheumatic medication selection for patients with rheumatoid arthritis. Medications are tailored to individual patients based on their genomic, clinical ...